– Company Expects to Initiate a Phase 1/2 Study for ALN-KHK in Early 2023, with Initial Results Expected in Late 2023 – “We are excited to advance ALN-KHK to the clinic as our first RNAi therapeutic ...
Nicholas Dreisbach (left) is a Senior Associate Scientist in the RNA team at ElevateBio (MA, USA), where he deploys his skills as an expert in capillary gel electrophoresis (CGE) technologies. His ...
Maravai LifeSciences’ MRVI business, TriLink BioTechnologies, recently partnered with Johns Hopkins University to significantly enhance research in RNA therapeutics. This collaboration aims to ...
Unlocking Precision: The BD PAXgene ® Blood RNA tubes, as part of the Cell and Biomarker Preservation portfolio for research tubes, are an essential component of the PAXgene ® Blood RNA System. This ...
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback